Literature DB >> 23038421

CSF1R mutations identified in three families with autosomal dominantly inherited leukoencephalopathy.

Jun Mitsui1, Takashi Matsukawa, Hiroyuki Ishiura, Koichiro Higasa, Jun Yoshimura, Taro L Saito, Budrul Ahsan, Yuji Takahashi, Jun Goto, Atsushi Iwata, Yuki Niimi, Yuuichi Riku, Yoji Goto, Kazuo Mano, Mari Yoshida, Shinichi Morishita, Shoji Tsuji.   

Abstract

Genetic and phenotypic heterogeneities are considerably high in adult-onset leukoencephalopathy, in which comprehensive mutational analyses of the candidate genes by conventional methods are too laborious. We applied exome sequencing to conduct a comprehensive mutational analysis of genes for autosomal dominant leukoencephalopathies. Genomic DNA samples from four patients of three families with autosomal dominantly inherited adult-onset leukodystrophy were subjected to exome sequencing. On the basis of the results, 21 patients with adult-onset sporadic leukodystrophy and one patient with pathologically proven HDLS were additionally screened for CSF1R mutations. Exome sequencing identified heterozygous CSF1R mutations (p.I794T and p.R777W) in two families. I794T has recently been reported as a causative mutation for hereditary diffuse leukoencephalopathy with spheroids (HDLS), and R777W is a novel mutation. Although mutational analysis of CSF1R in 21 sporadic cases revealed no mutations, another novel CSF1R mutation, p.C653Y, was identified in one patient with autopsy-proven HDSL. These variants were located in the PTK domain where the causative mutations cluster. Functional prediction of the mutant CSF1R as well as cross-species conservation of the affected amino acids supports the notion that these variants are pathogenic for HDLS. Exome sequencing is useful for a comprehensive mutational analysis of causative genes for hereditary leukoencephalopathies, and CSF1R should be considered a candidate gene for patients with autosomal dominant leukoencephalopathies.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038421     DOI: 10.1002/ajmg.b.32100

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  17 in total

1.  SIFT missense predictions for genomes.

Authors:  Robert Vaser; Swarnaseetha Adusumalli; Sim Ngak Leng; Mile Sikic; Pauline C Ng
Journal:  Nat Protoc       Date:  2015-12-03       Impact factor: 13.491

2.  Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Toshihiro Hayashi; Kayoko Saito; Hirokazu Furuya; Mitsunori Watanabe; Miho Murata; Mikiya Suzuki; Akira Sugiura; Setsu Sawai; Kazumoto Shibuya; Naohisa Ueda; Yaeko Ichikawa; Ichiro Kanazawa; Jun Goto; Shoji Tsuji
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

Review 3.  Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders.

Authors:  Todd E Golde
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

4.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

Authors:  Violeta Chitu; Solen Gokhan; Maria Gulinello; Craig A Branch; Madhuvati Patil; Ranu Basu; Corrina Stoddart; Mark F Mehler; E Richard Stanley
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

Review 5.  Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics.

Authors:  Carmen Stabile; Ilaria Taglia; Carla Battisti; Silvia Bianchi; Antonio Federico
Journal:  Neurol Sci       Date:  2016-06-23       Impact factor: 3.307

6.  Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia.

Authors:  Masanori Kurihara; Hiroyuki Ishiura; Takuya Sasaki; Juuri Otsuka; Toshihiro Hayashi; Yasuo Terao; Takashi Matsukawa; Jun Mitsui; Juntaro Kaneko; Kazutoshi Nishiyama; Koichiro Doi; Jun Yoshimura; Shinichi Morishita; Jun Shimizu; Shoji Tsuji
Journal:  Cerebellum       Date:  2018-04       Impact factor: 3.847

7.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.

Authors:  Elizabeth E Blue; Joshua C Bis; Michael O Dorschner; Debby W Tsuang; Sandra M Barral; Gary Beecham; Jennifer E Below; William S Bush; Mariusz Butkiewicz; Carlos Cruchaga; Anita DeStefano; Lindsay A Farrer; Alison Goate; Jonathan Haines; Jim Jaworski; Gyungah Jun; Brian Kunkle; Amanda Kuzma; Jenny J Lee; Kathryn L Lunetta; Yiyi Ma; Eden Martin; Adam Naj; Alejandro Q Nato; Patrick Navas; Hiep Nguyen; Christiane Reitz; Dolly Reyes; William Salerno; Gerard D Schellenberg; Sudha Seshadri; Harkirat Sohi; Timothy A Thornton; Otto Valadares; Cornelia van Duijn; Badri N Vardarajan; Li-San Wang; Eric Boerwinkle; Josée Dupuis; Margaret A Pericak-Vance; Richard Mayeux; Ellen M Wijsman
Journal:  Dement Geriatr Cogn Disord       Date:  2018-02-27       Impact factor: 2.959

8.  Hereditary diffuse leukoencephalopathy with axonal spheroids: three patients with stroke-like presentation carrying new mutations in the CSF1R gene.

Authors:  Carla Battisti; Ilaria Di Donato; Silvia Bianchi; Lucia Monti; Patrizia Formichi; Alessandra Rufa; Ilaria Taglia; Alfonso Cerase; Maria Teresa Dotti; Antonio Federico
Journal:  J Neurol       Date:  2014-02-16       Impact factor: 4.849

9.  [Hereditary diffuse leukencephalopathy with spheroids: a microgliopathy due to CSF1 receptor impairment].

Authors:  M Schuberth; J Levin; D Sawalhe; R Schwarzkopf; L von Baumgarten; B Ertl-Wagner; A Rominger; T Arzberger; H A Kretzschmar; T Froböse; J Diehl-Schmid; S Biskup; A Danek
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

Review 10.  Modeling CSF-1 receptor deficiency diseases - how close are we?

Authors:  Violeta Chitu; Şölen Gökhan; E Richard Stanley
Journal:  FEBS J       Date:  2021-07-05       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.